- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06829875
Are We Providing Timely Access to Musculoskeletal Outpatient Therapy Services? an Exploratory Study (MSk EATS)
Waiting times for NHS services are of growing public interest. This is because accessing some services is getting more difficult, and we know that longer waits can result in negative impacts for those waiting.
People in Wales waiting for care for their musculoskeletal problems are deemed to be cared for in good time if they get an appointment in less than 14 weeks. This target has been set by Welsh Government, for everyone who waits, no matter what condition they are waiting with and how that condition is affecting them.
We know that impact of wait for people with MSK problems can vary, from complete recovery, to worsening of their pain and function. The impact experienced seems to be influenced by factors such as their age and their mental health statusz\. This suggests that setting one target for all may not be the right thing to do. However, we don't yet know whether waiting over 14 weeks has a big effect on impact. We also don't know about the lived experience of those waiting, while they wait, despite knowing that learning this is vital to informing change.
We plan to study the impact of waiting for these services by asking those waiting to complete a survey that measures the impact of their msk problem, at the start and end of their wait, and then understanding how the scores correlate with length of time waited. We will also ask some of these people to document their experience as they wait. We hope that this will provide an understanding of how effective the current target is at measuring access to these services, and whether we need to think differently. People will be able to complete this work in their own home.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Access to NHS and social care services has been of increasing public interest for many years. Increasing waits to services has been long documented, and the COVID-19 pandemic saw waiting times soar to an all time high. This is not favourable because of the known negative impacts experienced by the waiter, when waiting longer for the services they need. Improving access to services is not only a National Driver featured throughout policy (A Healthier Wales, 2018) but a legal obligation (Duty of Quality, 2023). Access to services in Wales has been studied by Welsh Government for decades. This is usually measured by the time taken in weeks from referral to treatment, and is supported to be necessary in some areas, whereby increased waiting time can result in morbidity, or mortality, for example, heart attacks and strokes.
Literature exploring impact with wait is lacking when considering many areas of health, for example musculoskeletal conditions. However, such services are also duty bound to report their waiting times to Welsh Government.
Outpatient MSk Therapy Services, for example, report how long each person waits before an initial appointment is offered, in number of weeks. An appointment offered within 14 weeks of referral is considered 'timely' and people waiting over this time are considered to be 'breaching'. How this target became to be considered significant is not publicly justified. The impact of those waiting over 14 weeks on the person waiting, is not known.
Impact exploring those waiting for treatment for musuculoskeletal disorders is extremely limited. However, preliminary, retrospective study during COVID-19 suggests that those waiting for these services during this time, experienced a diversity of impact, from symptom recovery to deterioration of condition. The variables observed differed between individuals, as opposing to differing lengths of wait, and seemed to be influenced by personal factors such as socioeconomic and mental health status. This provides an insight that impact of wait is variable between individuals and does not align with current study of accessibility subjecting all people to the same arbitrary target without knowing what happens around this time. We know that future health and social care services need to be sustainable for the NHS to survive. We know that we need to look at things differently, considering the quality of the care that is provided rather than the quantity, and we are duty bound to explore how the NHS is doing with respect to quality, using both qualitative and quantitative information, involving all stakeholders. We know that this is vital to inform positive system change. However, there is no current exploration into the experience of waiting for MSk services, in the eyes of the waiter, as they wait.
Understanding this may help us to understand what a future model of MSk Outpatient healthcare should look like with respect to accessibility, and implement a sustainable solution for future generations. This is assuming that our current understanding of wait is inadequate, or not appropriate, based on the information available communicating accessibility through use of an arbitrary, unjustified blanket target for all, which remains an unknown.
This research project aims to understand the impact of chronological wait for people waiting for Musculoskeletal Therapy Outpatient Services, with reference given to under and over 14 weeks, to understand if the current target is effective at communicating how we are doing in this domain. It will also explore the lived experience of waiting in the eyes of the waiter, and seeks to understand whether this understanding aligns with what we see when studying impact of wait chronologically, with a view to provide a quality rich understanding of the impact of waiting for these services, and provide a direction of travel for future study.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Sara P James, MSc
- Phone Number: 07494885624
- Email: sara.james6@wales.nhs.uk
Study Contact Backup
- Name: Rachel Norman
- Email: rachel.norman2@wales.nhs.uk
Study Locations
-
-
Wales
-
Cardiff, Wales, United Kingdom
- Recruiting
- Cardiff and Vale University Healthboard
-
Contact:
- Sara P James, MSc
- Phone Number: 07494885624
- Email: sara.james6@wales.nhs.uk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- aged 18 years or over
- have entered a waiting list for outpatient podiatry, occupational therapy or physiotherapy with a musculoskeletal complaint
- able to provide informed consent
- be able to read and write english
Exclusion Criteria:
- are considered a vulnerable adult
- exhibit additional communication needs, to include but not limited to, language barrier
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
service users entering waiting lists for outpatient musculoskeletal physiotherapy, podiatry and OY
|
this is an observational study measuring impact of pain and function at start and end of wait for those waiting for care from outpatient physiotherapy occupations therapy and podiatry
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
musculoskeletal Health Questionnaire
Time Frame: from enrolment until the end of wait - currently up to 14 weeks
|
from enrolment until the end of wait - currently up to 14 weeks
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Sara P James, MSc, Cardiff And Vale University Health Board
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 8851
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Musculoskeletal
-
Al-Baha UniversityNot yet recruitingMusculoskeletal Disorders | Work-Related Musculoskeletal Disorders | Occupational Musculoskeletal Disorders
-
Laval UniversityCompletedMusculoskeletal DisorderCanada
-
Laval UniversityCompleted
-
Cairo UniversityNot yet recruiting
-
Wake Forest University Health SciencesRecruitingMusculoskeletal InjuryUnited States
-
Wroclaw University of Health and Sport SciencesUniversity School of Physical Education, Krakow, PolandCompletedMusculoskeletal DisorderPoland
-
Fondazione Policlinico Universitario Campus Bio-MedicoRecruiting
-
Norwegian University of Science and TechnologyNot yet recruitingSick Leave | MusculoskeletalNorway
-
Cairo UniversityNot yet recruiting
-
Aalborg UniversityDagrofa Logistics A/SCompletedWork-related Musculoskeletal DisordersDenmark
Clinical Trials on wait for outpatient appointment
-
Connolly Hospital BlanchardstownCompletedOutpatients General Surgery Virtual ClinicIreland
-
University of Alabama at BirminghamRecruitingDown Syndrome | Down Syndrome (Trisomy 21)United States
-
Berner Reha Zentrum AGUniversity of Zurich; Zurich University of Applied Sciences; Insel Gruppe AG,...RecruitingQuality of Life | Interstitial Lung Disease | Self Efficacy | Self-management | Patient Education | Fibrotic Lung DiseaseSwitzerland
-
Beijing Anzhen HospitalChinese PLA General HospitalUnknownDepression | Diabetes Mellitus, Type 2China
-
Clinique BizetNot yet recruiting
-
Medical College of WisconsinEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedPremature Birth | Decision Making | Resuscitation | Infant, Premature | Prenatal CareUnited States
-
Rush University Medical CenterStanford University; University of TorontoCompleted
-
University of North Carolina, Chapel HillNational Institute of Allergy and Infectious Diseases (NIAID); Palo Alto Medical...CompletedHealthy Men Age 50 Who Are Considering PSA ScreeningUnited States
-
University of ZurichSwiss Transfusion SRCCompletedBereavementSwitzerland
-
Centre Hospitalier Intercommunal CreteilRecruitingUrinary Tract Infections | Emerging Infectious Disease | Antiobiotic StewardshipFrance